Investor Relations
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>
Nov 08, 2018
OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018 MORE >>
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>

SEC Filings

Form Description Filing date View
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
8-K/A

Amendment to a previously filed 8-K

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
10KSB/A

Amendment to a previously filed 10KSB

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
S-3

Simplified registration form

View HTML
10KSB40

Optional form for annual and transition reports of small business issuers

View HTML
10QSB

Quarterly report filed by small businesses

View HTML